Webinar Series:
Investigating Generic Drugs

Join this urgent public discussion with patients, doctors, pharmacists, researchers and journalists to examine and improve generic drug safety and efficacy.

Register

WEBINAR #3 OF A SERIES | October 28 4:00-5:30 PM ET

Investigating Generic Drugs: Are Any of Us Safe from Faulty Generics?

Marta Wosińska, Ph.D Senior Fellow, Center on Health Policy,
The Brookings Institution
Suzanne Robotti Founder and President,
MedShadow Foundation
Reshma Ramachandran, M.D. Assistant Professor of Medicine (General Medicine) and Co-Director, Yale Collaboration for Regulatory Rigor, Integrity and Transparency,
Yale School of Medicine

REGISTER NOW

LEARN MORE ABOUT OUR WEBINAR SERIES

Watch on Demand

WEBINAR #1 OF A SERIES | June 15, 2025

Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

Watch

WEBINAR #3 OF A SERIES | October 28 4:00-5:30 PM ET

Investigating Generic Drugs: Are Any of Us Safe from Faulty Generics?

REGISTER NOW

WEBINAR #1 OF A SERIES | June 15, 2025

Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

Watch

WEBINAR #2 OF A SERIES | September 24, 2025 4:00–5:30 PM ET

Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

REGISTER NOW Watch

WEBINAR #3 OF A SERIES | October 28 4:00-5:30 PM ET

Investigating Generic Drugs: Are Any of Us Safe from Faulty Generics?

REGISTER NOW

Upcoming Webinars

WEBINAR #1 OF A SERIES | June 15, 2025

Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

WEBINAR #2 OF A SERIES | September 24, 2025 4:00–5:30 PM ET

Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

Read Related Articles:

INVESTIGATING GENERICS: America’s Overlooked Drug Crisis

INVESTIGATING GENERICS: They Say Their ADHD Meds Aren’t Working. They’re Not Imagining It

INVESTIGATING GENERICS: Hundreds Of Drugs Remain On The Market After Fraudulent Trials

Next

Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

x

x